{"default-task":"Task: Using the clinical note provided, answer the following questions - 1. What new TNF inhibitor (TNFi) biologic drug was prescribed or started? If the patient is not starting a new TNF inhibitor drug, write \"NA\" 2. What was the last TNF inhibitor drug the patient used? If none, write \"NA\" 3. Why was the last TNF inhibitor drug stopped or planned to be stopped? If no reason was provided or no TNFi was stopped, write \"NA\".\n\nUse the following format: {\"new_TNFi\":str, \"last_TNFi\":str, \"reason_last_TNFi_stopped\":str}\nAnswer:",
"drugs-provided":"Task: Cimzia (certolizumab), Enbrel (etanercept), Humira (adalimumab), Remicade (infliximab), Simponi (golimumab), Eticovo (etanercept-ykro), Erelzi (etanercept-szzs), Yuflyma (adalimumab-aaty), Idacio (adalimumab-aacf), Yusimry (adalimumab-aqvh), Hulio (adalimumab-fkjp), Abrilada (adalimumab-afzb), Hadlima (adalimumab-bwwd), Hyrimoz (adalimumab-adaz), Cyltezo (adalimumab-adbm), Amjevita (adalimumab-atto), Avsola (infliximab-axxq), Ixifi (infliximab-qbtx), Renflexis (infliximab-abda), Inflectra (infliximab-dyyb), and Renflixis (infliximab-abda) are tumor necrosis factor inihibitor (TNFi) biologic drugs. Using the clinical note provided, extract the following information into this JSON format: {\"new_TNFi\":\"What new TNFi was prescribed or started? If the patient is not starting a new TNFi, write \"NA\"\",\"last_TNFi\":\"What was the last TNFi the patient used? If none, write \"NA\"\",\"reason_last_TNFi_stopped\":\"Why was the last TNFi stopped or planned to be stopped? If no reason was provided or no TNFi was stopped, write \"NA\"\"}\nAnswer:",
"reasons-provided":"Task: Tumor necrosis factor inhibitors (TNFis) describe biologic drugs targeting TNF proteins. Using the clinical note provided, extract the following information into this JSON format: {\"new_TNFi\":\"What new TNFi was prescribed or started? If the patient is not starting a new TNFi, write \"NA\"\",\"last_TNFi\":\"What was the last TNFi the patient used? If none, write \"NA\"\",\"reason_type_last_TNFi_stopped\":\"Which best describes why the last TNFi was stopped or planned to be stopped? \"Adverse event\", \"Drug resistance\", \"Insurance/Cost\",\"Lack of efficacy\",\"Patient preference\",\"Other\", \"NA\"\",\"full_reason_last_TNFi_stopped\":\"Provide a description for why the last TNFi was stopped or planned to be stopped?\"}\nAnswer:",
"all-values-provided":"Task: Cimzia (certolizumab), Enbrel (etanercept), Humira (adalimumab), Remicade (infliximab), Simponi (golimumab), Eticovo (etanercept-ykro), Erelzi (etanercept-szzs), Yuflyma (adalimumab-aaty), Idacio (adalimumab-aacf), Yusimry (adalimumab-aqvh), Hulio (adalimumab-fkjp), Abrilada (adalimumab-afzb), Hadlima (adalimumab-bwwd), Hyrimoz (adalimumab-adaz), Cyltezo (adalimumab-adbm), Amjevita (adalimumab-atto), Avsola (infliximab-axxq), Ixifi (infliximab-qbtx), Renflexis (infliximab-abda), Inflectra (infliximab-dyyb), and Renflixis (infliximab-abda) are tumor necrosis factor inihibitor (TNFi) biologic drugs. Using the clinical note provided, extract the following information into this JSON format: {\"new_TNFi\":\"What new TNFi was prescribed or started? If the patient is not starting a new TNFi, write \"NA\"\",\"last_TNFi\":\"What was the last TNFi the patient used? If none, write \"NA\"\",\"reason_type_last_TNFi_stopped\":\"Which best describes why the last TNFi was stopped or planned to be stopped? \"Adverse event\", \"Drug resistance\", \"Insurance/Cost\",\"Lack of efficacy\",\"Patient preference\",\"Other\", \"NA\"\",\"full_reason_last_TNFi_stopped\":\"Provide a description for why the last TNFi was stopped or planned to be stopped?\"}\nAnswer:"}